Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value

Savino Sciascia, Nicola Bizzaro, Pier Luigi Meroni, Bogdanos Dimitrios, Maria Orietta Borghi, Xavier Bossuyt, Claudia Grossi, Dávid Tornai, Maria Papp, Yehuda Shoenfeld, Daniele Ielo*, Marvin J. Fritzler

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Abstract

Diagnosis of autoimmune diseases is in most cases challenging for clinicians as there is not a single specific laboratory or histological marker to diagnose or exclude the presence of the conditions. This review focused on the current knowledge of the role of autoantibodies' testing in various diseases, such as systemic lupus erythematosus, rheumatoid arthritis, antiphospholipid syndrome, undifferentiated connective tissues disease, primary biliary cholangitis and primary sclerosing cholangitis. Similarly, the prognostic and diagnostic values of autoantibodies testing in patients with interstitial lung disease have been reviewed. In-depth research on the molecular action of these autoantibodies on immune regulation and diseases pathogenesis has been explored beyond their correlation with disease phenotypes, highlighting the impact of autoantibodies targeting on disease outcomes and etiopathogenesis.

Original languageEnglish
Article number103356
JournalAutoimmunity Reviews
Volume22
Issue number7
DOIs
StatePublished - Jul 2023

Keywords

  • Antiphospholipid syndrome
  • Connective tissues disease
  • Interstitial lung disease
  • Primary biliary cirrhosis
  • Rheumatoid arthritis
  • Sclerosing cholangitis

Fingerprint

Dive into the research topics of 'Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value'. Together they form a unique fingerprint.

Cite this